PAKRX Mutual Fund

PAKRX Mutual Fund

NAV$15.63
See how much of PAKRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Sep 30, 2026

Net Assets
$6M
Expense Ratio
0.77%
Dividend Yield (Current)
6.78%
Holdings
28
Inception Date
Aug 20, 2013
Fund Family
T.Rowe Price
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.24%
1 Year+6.61%
3 Year+12.11%
5 Year+4.23%
10 Year+7.48%

Asset Allocation

Stocks: 0.75%
Other: 99.25%
See how much of PAKRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
TRPZXT. Rowe Price Ltd Dur Infl Focus Bd Z16.94%
-T. Rowe Price New Income Z13.66%
-T. Rowe Price Growth Stock Z8.67%
-T. Rowe Price Value Z8.49%
TRMZXTrp International Bd (Usd Hedged) - Z5.24%
Top 10 Concentration: 72.56%Report Date: Sep 30, 2026
Download all 28 holdings for PAKRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
6.78%
Frequency
Annually
Latest Distribution
$0.55
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

PAKRX Mutual Fund Overview

PAKRX Mutual Fund (T. Rowe Price Target 2030 Fund Adv Cl) is managed by T.Rowe Price with $6.3M in net assets. PAKRX expense ratio is 0.77%, holding 28 positions across various sectors. Inception date: 2013-08-20.

PAKRX performance shows a YTD return of 5.24%. The 1-year return is 6.61% and the 5-year return is 4.23%. PAKRX dividend yield stands at 6.78%, paid annually.

PAKRX top holdings include T. Rowe Price Ltd Dur Infl Focus Bd Z (16.9%), T. Rowe Price New Income Z (13.7%), T. Rowe Price Growth Stock Z (8.7%), T. Rowe Price Value Z (8.5%), Trp International Bd (Usd Hedged) - Z (5.2%). Go to all PAKRX holdings, PAKRX sectors, or PAKRX dividends.

PAKRX can be compared against other funds. Use PAKRX overlap to find shared positions, or PAKRX vs another fund for a side-by-side view. PAKRX alternatives are available via the screener, along with tax-loss harvesting opportunities.